Hyperlipidemia and renal disease: The use of animal models in understanding pathophysiology and approaches to treatment

Frazier T. Stevenson, George Kaysen

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Hyperlipidemia accelerates the progression of human renal disease, and its control is becoming an important component of therapy for patients with renal failure. The biologic basis for these observations remains poorly understood. This review summarizes recent data from animal models which show how lipoproteins interact with cells directly to cause renal injury. Data are presented from recent studies on the obese Zucker rat, a metabolic model of hyperlipidemia, obesity, and glomerular sclerosis, showing that triglyceride- containing lipoproteins may mediate glomerular injury. The biochemical basis for therapy is also discussed, including actions of lipid-lowering agents apart from their effect on serum lipids, and the use of polyunsaturated fatty acids as dietary therapy. Animal models are a crucial tool for the further elucidation of mechanisms of lipoprotein-mediated glomerular injury.

Original languageEnglish (US)
Pages (from-to)307-314
Number of pages8
JournalWiener Klinische Wochenschrift
Volume111
Issue number8
StatePublished - Apr 23 1999
Externally publishedYes

Fingerprint

Hyperlipidemias
Lipoproteins
Animal Models
Kidney
Wounds and Injuries
Lipids
Zucker Rats
Sclerosis
Unsaturated Fatty Acids
Renal Insufficiency
Triglycerides
Therapeutics
Obesity
Serum

Keywords

  • Animal models
  • Hyperlipidemia
  • Lipid lowering drugs
  • Polyunsaturated fatty acids
  • Progression
  • Renal disease

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Hyperlipidemia and renal disease : The use of animal models in understanding pathophysiology and approaches to treatment. / Stevenson, Frazier T.; Kaysen, George.

In: Wiener Klinische Wochenschrift, Vol. 111, No. 8, 23.04.1999, p. 307-314.

Research output: Contribution to journalArticle

@article{a6fa8f5faae64dad91e33c8f842ed541,
title = "Hyperlipidemia and renal disease: The use of animal models in understanding pathophysiology and approaches to treatment",
abstract = "Hyperlipidemia accelerates the progression of human renal disease, and its control is becoming an important component of therapy for patients with renal failure. The biologic basis for these observations remains poorly understood. This review summarizes recent data from animal models which show how lipoproteins interact with cells directly to cause renal injury. Data are presented from recent studies on the obese Zucker rat, a metabolic model of hyperlipidemia, obesity, and glomerular sclerosis, showing that triglyceride- containing lipoproteins may mediate glomerular injury. The biochemical basis for therapy is also discussed, including actions of lipid-lowering agents apart from their effect on serum lipids, and the use of polyunsaturated fatty acids as dietary therapy. Animal models are a crucial tool for the further elucidation of mechanisms of lipoprotein-mediated glomerular injury.",
keywords = "Animal models, Hyperlipidemia, Lipid lowering drugs, Polyunsaturated fatty acids, Progression, Renal disease",
author = "Stevenson, {Frazier T.} and George Kaysen",
year = "1999",
month = "4",
day = "23",
language = "English (US)",
volume = "111",
pages = "307--314",
journal = "Wiener Klinische Wochenschrift",
issn = "0043-5325",
publisher = "Springer Wien",
number = "8",

}

TY - JOUR

T1 - Hyperlipidemia and renal disease

T2 - The use of animal models in understanding pathophysiology and approaches to treatment

AU - Stevenson, Frazier T.

AU - Kaysen, George

PY - 1999/4/23

Y1 - 1999/4/23

N2 - Hyperlipidemia accelerates the progression of human renal disease, and its control is becoming an important component of therapy for patients with renal failure. The biologic basis for these observations remains poorly understood. This review summarizes recent data from animal models which show how lipoproteins interact with cells directly to cause renal injury. Data are presented from recent studies on the obese Zucker rat, a metabolic model of hyperlipidemia, obesity, and glomerular sclerosis, showing that triglyceride- containing lipoproteins may mediate glomerular injury. The biochemical basis for therapy is also discussed, including actions of lipid-lowering agents apart from their effect on serum lipids, and the use of polyunsaturated fatty acids as dietary therapy. Animal models are a crucial tool for the further elucidation of mechanisms of lipoprotein-mediated glomerular injury.

AB - Hyperlipidemia accelerates the progression of human renal disease, and its control is becoming an important component of therapy for patients with renal failure. The biologic basis for these observations remains poorly understood. This review summarizes recent data from animal models which show how lipoproteins interact with cells directly to cause renal injury. Data are presented from recent studies on the obese Zucker rat, a metabolic model of hyperlipidemia, obesity, and glomerular sclerosis, showing that triglyceride- containing lipoproteins may mediate glomerular injury. The biochemical basis for therapy is also discussed, including actions of lipid-lowering agents apart from their effect on serum lipids, and the use of polyunsaturated fatty acids as dietary therapy. Animal models are a crucial tool for the further elucidation of mechanisms of lipoprotein-mediated glomerular injury.

KW - Animal models

KW - Hyperlipidemia

KW - Lipid lowering drugs

KW - Polyunsaturated fatty acids

KW - Progression

KW - Renal disease

UR - http://www.scopus.com/inward/record.url?scp=0033597318&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033597318&partnerID=8YFLogxK

M3 - Article

C2 - 10378311

AN - SCOPUS:0033597318

VL - 111

SP - 307

EP - 314

JO - Wiener Klinische Wochenschrift

JF - Wiener Klinische Wochenschrift

SN - 0043-5325

IS - 8

ER -